DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function

Oncogene

Volumn 27, Issue 43, 2008, Pages 5706-5716

  Britschgi, A ^a   Trinh, E ^b   Rizzi, M ^a   Jenal, M ^a   Ress, A ^a   Tobler, A ^a,c   Fey, M F ^a,c   Helin, K ^b   Tschan, M P ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cell death; DAPK2; E2F1; KLF6; Sp1; Transcription

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE 2; KRUPPEL LIKE FACTOR 6; MITHRAMYCIN; MITHRAMYCIN A; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; EMBRYO; EXON; GC RICH SEQUENCE; GENE ACTIVATION; HUMAN; HUMAN CELL; INSECT CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BINDING SITES; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CELLS, CULTURED; E2F1 TRANSCRIPTION FACTOR; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; SP1 TRANSCRIPTION FACTOR;

HEXAPODA;

EID: 52949111324     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.179     Document Type: Article

References (50)

1. Andrews NC, Faller DV. (1991). A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian-cells. Nucleic Acids Res 19: 2499.
2. Bell LA, Ryan KM. (2003). Life and death decisions by E2F-1. Cell Death Differ 11: 137-142.
3. Bialik S, Kimchi A. (2006). The death-associated kinases: structure, function, and beyond. Ann Rev Biochem 75: 189-210.
4. Bieker JJ. (2001). Kruppel-like factors: three fingers in many pies. J Biol Chem 276: 34355-34358.
5. Black AR, Black JD, Azizkhan-Clifford J. (2001). Sp1 and Kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188: 143-160.
6. Blake MC, Jambou RC, Swick AG, Kahn JW, Azizkhan JC. (1990). Transcriptional initiation is controlled by upstream Gc-box Interactions in a tataa-less promoter. Mol Cell Biol 10: 6632-6641.
7. Botella LM, Sanchez-Elsner T, Sanz-Rodriguez F, Kojima S, Shimada J, Guerrero-Esteo M et al. (2002). Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury. Blood 100: 4001-4010.
8. Britschgi C, Rizzi M, Grob TJ, Tschan MP, Hugli B, Reddy VA et al. (2006). Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1. Oncogene 25: 2030-2039.
9. Chen CS, Hyytinen ER, Sun XD, Helin HJ, Koivisto PA, Frierson HF et al. (2003). Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am J Pathol 162: 1349-1354.
10. Christoph F, Kempkensteffen C, Weikert S, Kollermann J, Krause H, Miller K et al. (2006). Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer. Br J Cancer 95: 1701-1707.
11. DeGregori J, Johnson DG. (2006). Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 6: 739-748.
12. Denchi EL, Helin K. (2005). E2F1 is crucial for E2F-dependent apoptosis. EMBO Rep 6: 661-667.
13. Difeo A, Narla G, Hirshfeld J, Camacho-Vanegas O, Narla J, Rose SL et al. (2006). Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination. Clin Cancer Res 12: 3730-3739.
14. Esteller M, Corn PG, Baylin SB, Herman JG. (2001). A gene hypermethylation profile of human cancer. Cancer Res 61: 3225-3229.
15. Geng Y, Eaton EN, Picon M, Roberts JM, Lundberg AS, Gifford A et al. (1996). Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12: 1173-1180.
16. Hershko T, Ginsberg D. (2004). Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J Biol Chem 279: 8627-8634.
17. Inbal B, Shani G, Cohen O, Kissil JL, Kimchi A. (2000). Death-associated protein kinase-related protein 1, a novel serine/threonine kinase involved in apoptosis. Mol Cell Biol 20: 1044-1054.
18. Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W et al. (2000). Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407: 645-648.
19. Ito G, Uchiyama M, Kondo M, Mori S, Usami N, Maeda O et al. (2004). Kruppel-Like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells. Cancer Res 64: 3838-3843.
20. Karlseder J, Rotheneder H, Wintersberger E. (1996). Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol Cell Biol 16: 1659-1667.
21. Katzenellenbogen RA, Baylin SB, Herman JG. (1999). Hypermethylation of the DAP-Kinase CpG island is a common alteration in B-cell malignancies. Blood 93: 4347-4353.
22. Kim Y, Ratziu V, Choi SG, Lalazar A, Theiss G, Dang Q et al. (1998). Transcriptional activation of transforming growth factor beta 1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1 - potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem 273: 33750-33758.
23. Kollmar R, Sukow KA, Sponagle SK, Farnham PJ. (1994). Start site selection at the tata-less carbamoyl-phosphate synthase (glutamine-hydrolyzing) aspartate carbamoyltransferase dihydroorotase promoter. J Biol Chem 269: 2252-2257.
24. Koutsodontis G, Kardassis D. (2004). Inhibition of p53-mediated transcriptional responses by mithramycin A. Oncogene 23: 9190-9200.
25. Kramps C, Strieder V, Sapetschnig A, Suske G, Lutz W. (2004). E2F and Sp1/Sp3 synergize but are not sufficient to activate the MYCN gene in neuroblastomas. J Biol Chem 279: 5110-5117.
26. Li D, Yea S, Dolios G, Martignetti JA, Narla G, Wang R et al. (2005). Regulation of Kruppel-like factor 6 tumor suppressor activity by acetylation. Cancer Res 65: 9216-9225.
27. Lin SY, Black AR, Kostic D, Pajovic S, Hoover CN, Azizkhan JC. (1996). Cell cycle-regulated association of E2F1 and sp1 is related to their functional interaction. Mol Cell Biol 16: 1668-1675.
28. Maruyama R, Toyooka S, Toyooka KO, Harada K, Virmani AK, Zochbauer-Muller S et al. (2001). Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res 61: 8659-8663.
29. Miller DM, Polansky DA, Thomas SD, Ray R, Campbell VW, Sanchez J et al. (1987). Mithramycin selectively inhibits transcription of G-C containing DNA. Am J Med Sci 294: 388-394.
30. Moroni MC, Hickman ES, Lazzerini Denchi E, Caprara G, Colli E, Cecconi F et al. (2001). Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 3: 552-558.
31. Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E et al. (2001). E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 15: 267-285.
32. Narla G, Friedman SL, Martignetti JA. (2003). Kruppel cripples prostate cancer - KLF6 progress and prospects. Am J Pathol 162: 1047-1052.
33. Narla G, Heath KE, Reeves HL, Li D, Giono LE, Kimmelman AC et al. (2001). KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 294: 2563-2566.
34. Parisi T, Pollice A, Di Cristofano A, Calabro V, La Mantia G. (2002). Transcriptional regulation of the human tumor suppressor p14(ARF) by E2F1, E2F2, E2F3, and Sp1-like factors. Biochem Biophys Res Commun 291: 1138-1145.
35. Park KK, Rue SW, Lee IS, Kim HC, Lee IK, Ahn JD et al. (2003). Modulation of Sp1-dependent transcription by a cis-acting E2F element in dhfr promoter. Biochem Biophys Res Commun 306: 239-243.
36. Putzer BM. (2007). E2F1 death pathways as targets for cancer therapy. J Cell Mol Med 11: 239-251.
37. Radziwill G, Erdmann RA, Margelisch U, Moelling K. (2003). The Bcr kinase downregulates ras signaling by phosphorylating AF-6 and binding to its PDZ domain. Mol Cell Biol 23: 4663-4672.
38. Reeves HL, Narla G, Ogunbiyi O, Haq AI, Katz A, Benzeno S et al. (2004). Kruppel-Like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer. Gastroenterology 126: 1090-1103.
39. Rizzi M, Tschan MP, Britschgi C, Britschgi A, Hugli B, Grob TJ et al. (2007). The death-associated protein kinase 2 is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cells. J Leukoc Biol 81: 1599-1608.
40. Robertson KD, Jones PA. (1998). The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol Cell Biol 18: 6457-6473.
41. Shohat G, Shani G, Eisenstein M, Kimchi A. (2002). The DAP-kinase family of proteins: study of a novel group of calcium-regulated death-promoting kinases. Biochim Biophys Acta (BBA) - Prot Proteom 1600: 45-50.
42. Slavin DA, Koritschoner NP, Prieto CC, Lopez-Diaz FJ, Chatton B, Bocco JL. (2004). A new role for the Kruppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function. Oncogene 23: 8196-8205.
43. Stanelle J, Tu-Rapp H, Putzer BM. (2005). A novel mitochondrial protein DIPmediat es E2F1-induced apoptosis independently of p53. Cell Death Differ 12: 347-357.
44. Suske G. (1999). The Sp-family of transcription factors. Gene 238: 291-300.
45. Suzuki T, Aizawa K, Matsumura T, Nagai R. (2005). Vascular implications of the Kruppel-like family of transcription factors. Arterioscler Thromb Vasc Biol 25: 1135-1141.
46. Tschan MP, Fischer KM, Fung VS, Pirnia F, Borner MM, Fey MF et al. (2003). Alternative splicing of the human cyclin D-binding Myb-like protein (hDMP1) yields a truncated protein isoform that alters macrophage differentiation patterns. J Biol Chem 278: 42750-42760.
47. Turner J, Crossley M. (1999). Mammalian Kruppel-like transcription factors: more than just a pretty finger. Trends Biochem Sci 24: 236-241.
48. Voso MT, Scardocci A, Guidi F, Zini G, Di Mario A, Pagano L et al. (2004). Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes. Blood 103: 698-700.
49. Xie W, Jiang P, Miao L, Zhao Y, Zhimin Z, Qing L et al. (2006). Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1. Nucleic Acids Res 34: 2046-2055.
50. Yin D, Komatsu N, Miller CW, Chumakov AM, Marschesky A, McKenna R et al. (2007). KLF6: Mutational analysis and effect on cancer cell proliferation. Int J Oncol 30: 65-72.